公告 Statement of changes in beneficial ownership of securities

发表于 2020-10-01 08:59   3156次浏览

公告 Initial statement of beneficial ownership of securities

发表于 2020-10-01 08:48   2920次浏览

公告 Statement of acquisition of beneficial ownership by individuals

发表于 2020-10-01 04:36   2866次浏览

公告 [Amend] Solicitation, recommendation statements

发表于 2020-09-30 20:37   2842次浏览

公告 [Amend] Tender offer statement by Third Party

发表于 2020-09-30 20:36   2865次浏览

公告 Confidential treatment order

发表于 2020-09-23 00:42   2779次浏览

公告 [Amend] Solicitation, recommendation statements

发表于 2020-09-19 05:33   2846次浏览

公告 [Amend] Solicitation, recommendation statements

发表于 2020-09-16 18:39   2838次浏览

公告 [Amend] Tender offer statement by Third Party

发表于 2020-09-16 18:35   2871次浏览

公告 [Amend] Tender offer statement by Third Party

发表于 2020-09-11 19:42   2942次浏览

公告 [Amend] Solicitation, recommendation statements

发表于 2020-09-11 19:42   2872次浏览

公告 Solicitation, recommendation statements

发表于 2020-08-31 21:22   2890次浏览

公告 Tender offer statement by Third Party

发表于 2020-08-31 21:22   3019次浏览

公告 Written communication relating to third party tender offer

发表于 2020-08-24 20:43   2945次浏览

公告 General statement of acquisition of beneficial ownership

发表于 2020-08-22 04:52   2943次浏览

公告 Written communication relating to third party tender offer

发表于 2020-08-13 21:13   2967次浏览

【PFNX】2020-08-11/(1)全国知名的股东权利律师事务所Bragar

【PFNX】2020-08-11/(1)全国知名的股东权利律师事务所BragarEagel＆SquirePC已开始调查配体制药PfenexInc.（NYSE：PFNX）的董事会成员是否违反了与该公司合并相关的信托义务或违反了联邦证券法。(2)PFNX7月份赢得与Inovio的专利裁决后股价上涨。(3)Inovio称购买Pfenex配体的法规受到挫折，Inovio表示第2/3期冠状病毒疫苗研究...

公告 Written communication relating to third party tender offer

发表于 2020-08-11 18:31   3033次浏览

公告 Current report, items 1.01, 8.01, and 9.01

发表于 2020-08-11 18:31   2981次浏览

公告 Written communication relating to an issuer or third party

发表于 2020-08-11 18:20   2986次浏览